aSAH	Aneurysmal subarachnoid hemorrhage
CVS	Cerebral vasospasm
DCI	Delayed cerebral ischemia
BBB	Blood-brainbarrier
CSF	Cerebrospinal fluid
TLR4	Toll-like receptor 4
NADPH	Nicotinamide adenine dinucleotide phosphate
CNS	Central nervous system
IL	Interleukin
TNFα	Tumor necrosis factor alpha
NF-kB	Nuclear factor kappa-light-chain-enhancer of activated B cells
eCBs	Endocannabinoids
AEA	Anandamide
2-AG	2-arachidonoyl-glycerol
ECS	Endocannabinoid system
CBRs	Cannabinoid receptors
CB1R	Cannabinoid type 1 receptor
CB2R	Cannabinoid type 2 receptor
MMPs	Metalloproteinases
HMGB1	High mobility group box 1
TBI	Traumatic brain injury
EBI	Early brain injury
DAMP	Damage-associated molecular pattern
RAGE	Receptor for advanced glycation end products
JAK2	Janus-Kinase 2
STAT3	Signal transducer and activator of transcription 3
COX-2	Cyclooxygenase-2
PGE-2	Prostaglandin E2
IL-1Ra	IL-1 receptor antagonist
vWF	von Willebrand Factor
ADAMTS-13	A disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13
tPA	Tissue plasminogen activator+
GP	Platelet glycoprotein
ICH	Intracerebral hemorrhage
ICP	Intracranial pressure
CPP	Cerebral perfusion pressure
CBF	Cerebral blood flow
MABP	Mean artery blood pressure
ATP	Adenosine triphosphate
LPR	Lactate-to-pyruvate ratio
CMD	Cerebral microdialysis
CMRO2	Cerebral metabolic rate for oxygen
PET	Positron emission tomography
ptiO2	Tissue oxygenation
PDH	Pyruvate dehydrogenase
DCA	Dichloroacetate
ALCAR	Acetyl-L-carnitine
EGCG	Epigallocatechin-3-gallate
PaCO2	Arterial partial pressure of carbon dioxide